Form 4: CapsoVision Director Julia Gouw Acquires RSUs

Sentiment:

Insider Transaction Report


CapsoVision Director Julia S. Gouw acquired 2,887 Restricted Stock Units, scheduled to vest on December 31, 2025, under a Rule 10b5-1 plan.

Summary

  • Julia S. Gouw, a Director of CapsoVision, Inc. (CV), acquired 2,887 Restricted Stock Units (RSUs) on September 15, 2025.
  • Each RSU represents a contingent right to receive one share of CapsoVision's common stock.
  • The acquisition was made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
  • These RSUs are scheduled to vest on December 31, 2025.
  • Following this transaction, Julia S. Gouw beneficially owns 2,887 derivative securities (RSUs) directly.

Sentiment

Score: 6

Explanation: The filing indicates a routine insider equity grant under a 10b5-1 plan, which is a neutral to slightly positive event as it aligns director interests with shareholders without suggesting any immediate operational or financial changes.

Positives

  • The acquisition of Restricted Stock Units by a director aligns management's interests with those of shareholders, potentially motivating long-term performance.
  • The transaction was conducted under a Rule 10b5-1 plan, indicating a pre-arranged, non-opportunistic acquisition, which is a positive governance practice.

Future Outlook

The acquired Restricted Stock Units are scheduled to vest on December 31, 2025, at which point they will convert into shares of CapsoVision's common stock, subject to the terms of the RSU agreement.

Industry Context

Equity compensation, such as Restricted Stock Units, is a standard practice across various industries for attracting, retaining, and incentivizing directors and executives. The use of Rule 10b5-1 plans for such grants is also a common governance practice to mitigate concerns about insider trading.

Comparison to Industry Standards

  • The grant of Restricted Stock Units to a director is a common form of equity compensation, comparable to practices at many publicly traded companies in the healthcare technology sector and broader markets.
  • The use of a Rule 10b5-1 plan for this transaction aligns with best practices for insider trading compliance, similar to policies adopted by leading companies to ensure transparency and reduce perceptions of opportunistic trading.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Insider Trading Policy AdherenceThe transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).09/15/2025This indicates adherence to robust insider trading policies, enhancing transparency and mitigating potential conflicts of interest by pre-scheduling transactions.

Related Party Transactions

  • The acquisition of Restricted Stock Units by Julia S. Gouw, a Director, represents a form of compensation from the issuer, which is a common related-party transaction in the context of executive and director remuneration.

Stakeholder Impact

  • Shareholders: The grant of RSUs to a director can enhance alignment between management and shareholder interests, potentially leading to better long-term performance.
  • Employees: While not directly impacting general employees, such compensation practices are part of the overall corporate reward structure.

Next Steps

  • The Restricted Stock Units are scheduled to vest on December 31, 2025, at which point Julia S. Gouw will receive the underlying common stock.

Key Dates

DateDescription
09/15/2025Date of transaction for the acquisition of Restricted Stock Units.
09/17/2025Date the Form 4 statement was signed and filed.
12/31/2025Scheduled vesting date for the acquired Restricted Stock Units.

Keywords

CapsoVision, CV, Julia S. Gouw, Form 4, Restricted Stock Unit, RSU, Insider Transaction, Director Compensation, Equity Compensation, Rule 10b5-1

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.